Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection-Reference-Cited by-同舟云学术

Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection

Published:2014-04 Issue: Volume:104 Page:102-109
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Ogawa Eiichi,Furusyo Norihiro,Kajiwara Eiji,Nomura Hideyuki,Dohmen Kazufumi,Takahashi Kazuhiro,Nakamuta Makoto,Satoh Takeaki,Azuma Koichi,Kawano Akira,Tanabe Yuichi,Kotoh Kazuhiro,Shimoda Shinji,Hayashi Jun

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference35 articles.

1. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor;Agnello;Proc. Natl. Acad. Sci. USA,1999

2. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group;Bedossa;Hepatology,1996

3. Predictors of virologic response with telaprevir-based combination treatment HCV genotype1 infected patients with prior peginterferon/ribavirin treatment failure: post hoc analysis of the phase III REALIZE study;Berg;Hepatology,2011

4. Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir;Boglione;J. Viral. Hepat.,2013

5. Primary liver cancer: worldwide incidence and trends;Bosch;Gastroenterology,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of Lipid Metabolism in HCV Infection;Клиническая инфектология и паразитология;2021-02-11

2. The interrelation between lipid profile in chronic HCV patients and their response to antiviral agents;Expert Review of Gastroenterology & Hepatology;2020-11-02

3. Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy;Annals of Hepatology;2018-11

4. Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment;Internal Medicine;2018-05-01

5. Serum WFA+-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C;Alimentary Pharmacology & Therapeutics;2015-10-26